Cargando…

S81. Proffered paper: A new PD1-CD28 chimeric receptor overcomes PD-1-mediated immunosuppression in adoptive T cell therapy

Detalles Bibliográficos
Autores principales:	Grassmann, S, Peters, P, Zeng, Y, Schmollinger, J, Endres, S, Kobold, S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Invited Speaker Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4072111/ http://dx.doi.org/10.1186/2051-1426-2-S2-I19

Ejemplares similares

S9. Proffered paper: Identification of novel immune checkpoints as targets for cancer immunotherapy
por: Cojocaru, G, et al.
Publicado: (2014)

S82. Proffered paper: In-vivo testing of PSMA-targeted T-cell immunotherapy for prostate cancer
por: Liu, Z, et al.
Publicado: (2014)

S78. Proffered paper: High-affinity CD20-specific TCRs suitable for adoptive immunotherapy can be readily isolated from the allo-repertoire using reverse immunology
por: Jahn, L, et al.
Publicado: (2014)

S50. Proffered paper: Complex tumour microenvironment screening platform captures biological responses of cancer therapeutics
por: Layman, H, et al.
Publicado: (2014)

S77. Proffered paper: In vitro induced response patterns of antileukemic T-cells – characterization by combination of functional assays, spectratyping and next generation sequencing
por: Reuther, S, et al.
Publicado: (2014)

S6. Proffered paper: Anti-tumour immunomodulatory activity of heat shock protein Hsp70 in therapy of malignant brain tumours: preclinical and clinical data
por: Shevtsov, M, et al.
Publicado: (2014)

S5. Proffered paper: Maintenance therapy of metastatic colorectal carcinoma with the TLR-9 agonist MGN1703: clinical and immunological predictive pretreatment factors of activity in the IMPACT trial
por: Schmoll, H, et al.
Publicado: (2014)

PD1-CD28 Fusion Protein Enables CD4+ T Cell Help for Adoptive T Cell Therapy in Models of Pancreatic Cancer and Non-hodgkin Lymphoma
por: Rataj, Felicitas, et al.
Publicado: (2018)

Parallel Sessions (Proffered Papers)
Publicado: (2010)

Parallel Sessions (Proffered Papers)
Publicado: (2008)

S76. Adoptive cell therapy of melanoma with autologous tumour infiltrating lymphocytes
por: Svane, I, et al.
Publicado: (2014)

S2. Therapeutic strategies based on overcoming immune resistance mechanisms within the melanoma tumour microenvironment
por: Gajewski, T
Publicado: (2014)

P68. A new EGFR - EpCAM bispecific antibody enhances the efficacy of adoptive T-cell therapy in a murine gastric tumour model
por: Kobold, S, et al.
Publicado: (2014)

Part I: Abstracts of Members' Proffered Papers
Publicado: (1976)

PD-1-CD28 fusion protein strengthens mesothelin-specific TRuC T cells in preclinical solid tumor models
por: Lesch, Stefanie, et al.
Publicado: (2022)

INSP-06. Recent advances in improving neuropsychological outcomes for paediatric brain tumour patients - Are we entering a new era?
por: Mabbott, Donald
Publicado: (2022)

INSP-09. Using genetically engineered mouse models and patient-derived orthotopic xenografts to develop new therapies for pediatric brain tumors.
por: Jonchere, Barbara, et al.
Publicado: (2022)

INSP-04. Confirmatory adaptive designs for survival trials with several time-to-event endpoints
por: Schmidt, Rene
Publicado: (2022)

INSP-08. Cerebellar mutism syndrome: incidence, symptoms, risk factors, prognosis. Results and future perspectives from the Nordic-European study of the cerebellar mutism syndrome
por: Sehested, Astrid, et al.
Publicado: (2022)

INSP-03. Neuronal regulation of glioma progression
por: Monje, Michelle
Publicado: (2022)

INSP-17. Augmented Drug Delivery for Pediatric Diffuse Midline Glioma using Convection Enhanced Delivery
por: Souweidane, Mark M
Publicado: (2022)

INSP-14. Novel approaches to molecular diagnostics
por: Sahm, Felix
Publicado: (2022)

INSP-07. Improving cognitive outcomes for children treated for cancer: moving beyond the cure
por: Conklin, Heather
Publicado: (2022)

INSP-01. What to do when you cannot randomize? Leveraging Historical Data in Efficient Study Designs for Pediatric Neuro-Oncology.
por: Onar-Thomas, Arzu
Publicado: (2022)

INSP-02. WHO 2021 classification of CNS tumors
por: Wesseling, Pieter
Publicado: (2022)

INSP-16. Focused ultrasound-mediated blood-brain barrier disruption for the treatment of pediatric high-grade glioma
por: van Vuurden, Dannis, et al.
Publicado: (2022)

INSP-05. Development of fast cortical rhythms in health and mental disease
por: Hanganu-Opatz, Ileana
Publicado: (2022)

PD-1/PD-L1 blockade in cancer treatment: perspectives and issues
por: Hamanishi, Junzo, et al.
Publicado: (2016)

Type 1 regulatory T (Tr1) cells: from the bench to the bedside
por: Gregori, Silvia, et al.
Publicado: (2012)

Liver transplantation in HIV-1-infected patients
por: Miró, José M
Publicado: (2010)

The ups and downs of HIV-1 gene expression
por: Kiernan, Rosemary E
Publicado: (2009)

Host genome influences on susceptibility to HIV-1
por: Telenti, Amalio
Publicado: (2009)

NK Cells and immune activation in HIV-1 infection
por: Goodier, Martin R
Publicado: (2010)

Role of regulatory T cells in the pathogenesis of HIV-1 infection
por: Lévy, Yves
Publicado: (2009)

Rationale of combination of anti-PD-1/PD-L1 antibody therapy and radiotherapy for cancer treatment
por: Sato, Hiro, et al.
Publicado: (2020)

I-1 History of Myology in Italy and its international collections
por: Angelini, C.
Publicado: (2011)

Dynamic interplay between HIV-1 integrase and host cofactors
por: Emiliani, Stéphane
Publicado: (2009)

Novel and unexpected cellular partners for HIV-1 integrase and Tat
por: Giacca, Mauro
Publicado: (2009)

Molecular control of HIV - 1 postintegration latency: implications for therapeutic strategies
por: Van Lint, Carine
Publicado: (2012)

Novel cellular processes that regulate post-transcriptional expression of HIV-1 transcripts
por: Jeang, Kuan-Teh
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_84lbpdsnlsa8i3juij16nhcpf4